---
$id: https://graph.org.ai/products/commodity/51201825
$type: Product
source: UNSPSC
code: "51201825"
title: "Betazole hydrochloride"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Betazole hydrochloride

**UNSPSC Code**: 51201825
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a diagnostic reagent with the molecular formula C5H9N3.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 66ABP6C83F, chemically known as 3,5-beta-pyrazoleethylamine dihydrochloride but more generally known as betazole hydrochloride, which bears US NIH Compound Identifier 67412. The base compound, betazole, most often comes in base, dihydrochloride, and hydrochloride forms. European Medicines Agency schedules Betazole hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00789MIG. Most nations, for tariff and trade purposes, schedule betazole hydrochloride under HS 29331990 and SITC 51571. As of Q4 2014, BETAZOLE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Betazole hydrochloride bears US NLM identifiers UMLS ID C1879837 and NCI Concept Code C65259. SMILES: C1C[NH]NC1CCN.CL.CL.

